Stay updated on Lomvastomig vs Nivolumab in Esophageal SCC Clinical Trial
Sign up to get notified when there's something new on the Lomvastomig vs Nivolumab in Esophageal SCC Clinical Trial page.

Latest updates to the Lomvastomig vs Nivolumab in Esophageal SCC Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe record history now shows a new revision entry v3.5.4 and removes v3.5.3 from the list. This reflects an internal update to the page's versioning.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe page’s interface/version indicator was updated from revision v3.5.2 to v3.5.3, reflecting a maintenance or UI release rather than a change to the trial record itself.SummaryDifference0.1%

- Check43 days agoChange DetectedRevision: v3.5.2 was added to the history. Revision: v3.5.0 was removed from the history.SummaryDifference0.1%

- Check57 days agoChange DetectedNew results have been posted, and the Outcomes Measures, Results, and Study Status sections have been updated.SummaryDifference0.4%

- Check71 days agoChange DetectedAdded Revision: v3.5.0 to the record history and removed Revision: v3.4.3.SummaryDifference0.1%

- Check79 days agoChange DetectedAdded a new site revision entry v3.4.3 and removed the previous v3.4.2 entry from the history.SummaryDifference0.1%

Stay in the know with updates to Lomvastomig vs Nivolumab in Esophageal SCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lomvastomig vs Nivolumab in Esophageal SCC Clinical Trial page.